DEA Training

TABLE OF CONTENTS

Stanford's DEA MATE program offers on-demand content covering various topics related to opioid prescribing and pain management, as required by the Medication Access and Training Expansion (MATE) Act. The training is customized for different provider groups to make it more relevant to their specific needs. Learners can complete the activities at their own pace and in any combination to meet any training requirements.

The topics covered include:

Drug Regulation and Opioid Misuse in the U.S.
Opioid Prescription and Management
Treatment for Opioid Use Disorder
Pain Management in Special Populations
Prevention and Treatment of Substance Use Disorders

These modules are designed to provide comprehensive and up-to-date information on this important topic. As a benefit to our community, Stanford Clinicians and Affiliates can enroll in these modules at no cost using the registration comp code.

Free to Stanford and Stanford Affiliate Learners

Drug Approval and Scheduling | Online Interactive Module

Getting High-Tech: Safe Opioid Prescribing in the Era of Technology | Online Interactive Module

Factors Associated with Prescription Opioid Misuse | OnDemand Video

Opioid Use Disorder: Adult and Pediatric Considerations | Online Interactive Module

Cannabinoids: A Clinical Perspective | OnDemand Video

Evidenced-Based, Non-pharmacologic approaches to treatment of SUD and Chronic Pain | OnDemand Video

Non-Opioid Adjuvants for the Opioid Tolerant or Opioid Use Disorder Patient | Online Interactive Module

Fundamentals of Urine Drug Testing | Online Interactive Module

Abuse-Deterrent Drug Formulations | OnDemand Video

Management of the Opioid Tolerant Patient in Acute Pain: Perioperative Buprenorphine Management | Online Interactive Module

Stimulant Use in the Perioperative Period | Online Interactive Module

Analgesic Management of the Opioid-Dependent Parturient | Online Interactive Module

Exploring the Evidence-Based Use of Cannabinoids in Pediatric Pain | Online Interactive Module

Management of Pain, Opioids, and Dependence in the Pediatric Population | OnDemand Video

Opioid Use Disorder in the Pediatric and Adolescent Population | OnDemand Video

Epidemiology of Adolescent Opioid Use | OnDemand Video

Additional DEA MATE Resources

Who is required?

What is the deadline?

The deadline for satisfying this new training requirement is the date of a practitioner’s next scheduled DEA registration submission—regardless of whether it is an initial registration or a renewal registration—on or after June 27, 2023.

• This one-time training requirement affirmation will not be a part of future registration renewals.

Who is exempted?

Group 1: All practitioners that are board certified in addiction medicine or addiction psychiatry from the American Board of Medical Specialties, the American Board of Addiction Medicine, or the American Osteopathic Association.

Group 2: All practitioners that graduated in good standing from a medical (allopathic or osteopathic), dental, physician assistant, or advanced practice nursing school in the United States within five years of June 27, 2023, and successfully completed a comprehensive curriculum that included at least eight hours of training on: Treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all drugs approved by the Food and Drug Administration for the treatment of a substance use disorder; or Safe pharmacological management of dental pain and screening, brief intervention, and referral for appropriate treatment of patients with or at risk of developing opioid and other substance use disorders.

How to satisfy the requirements

Practitioners can satisfy this training by engaging in a total of eight hours of training on treatment and management of patients with opioid or other substance use disorders from the groups listed below. A few key points related to this training:

The training does not have to occur in one session. It can be cumulative across multiple sessions that equal eight hours of training.
Past trainings on the treatment and management of patients with opioid or other substance use disorders can count towards a practitioner meeting this requirement. In other words, if you received a relevant training from one of the groups listed below— prior to the enactment of this new training obligation on December 29, 2022—that training counts towards the eight-hour requirement.
★ Note to CA Physicians from CMA: According to the California Medical Association, California physicians who have already completed the 12 hours of CME on pain management and end of life care required by the state may be able to use those credits to meet a portion of the new DEA requirement.
Past DATA-Waived trainings count towards a DEA registrant’s 8-hour training requirement.
Trainings can occur in a variety of formats, including classroom settings, seminars at professional society meetings, or virtual offerings.

Statutes, Regulations, Guidelines

To ensure compliance with evolving requirements, practitioners and opioid treatment programs (OTPs) should proactively familiarize themselves with the latest federal statutes, regulations, and guidelines governing medications. These resources provide crucial information and guidance for practitioners and OTPs in managing and administering medications effectively. By staying informed and up-to-date, practitioners and OTPs can ensure safe and lawful practices in their treatment programs.

Resources

To assist you, we have compiled a selection of available trainings for your convenience. Please note that this list may not cover all available options, and unless specified, Stanford University was not involved in the development of these trainings. We will continue to provide updates as we become aware of additional training opportunities.

Find a doctor

Clinics & Services

Research Resources

Professional Training

Education Resources